Related articles

• Randomized Controlled Trial

  All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study.

  Lancet. 2014 Nov 1; 384 (9954): 1597-605.

• Randomized Controlled Trial

  Efficacy of nucleotide polymerase inhibitor sofosbuvir plus the NS5A inhibitor ledipasvir or the NS5B non-nucleoside inhibitor GS-9669 against HCV genotype 1 infection.

  Gastroenterology. 2014 Mar 1;146(3):736-743.e1.

• Randomized Controlled Trial

  Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial.

  Lancet. 2014 Aug 2;384(9941):414-26.

Show more related articles...